Dyskeratosis congenita: New clinical and molecular insights into ribosome function

Lancet

Volumn 353, Issue 9160, 1999, Pages 1204-1205

  McGrath, J A ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOSOME RNA;

BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; CYTOPENIA; DISEASE CARRIER; DYSKERATOSIS CONGENITA; GENE LOCUS; GENE MUTATION; HEMATOPOIESIS; HUMAN; LUNG DISEASE; LUNG FIBROSIS; MOLECULAR CLONING; MOLECULAR GENETICS; NOTE; PRIORITY JOURNAL; REGISTER; RIBOSOME;

EID: 0033541581     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)00011-2     Document Type: Note

References (6)

1. F Zinsser Atrophia cutis reticularis cum pigmentatione, dystrophia unguium et leukoplakia oris Ikonogr Dermatol (Hyoto) 5 1906 219 223
2. S Knight T Vulliamy A Copplestone E Gluckman P Mason I Dokal Dyskeratosis congenita (DC) registry:identification of new features of DC Br J Haematol 103 1998 990 996
3. NS Heiss SW Knight TJ Vulliamy X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions Nat Genet 19 1998 32 38
4. L Luzzatto A Karadimitris Dyskeratosis and ribosomal rebellion Nat Genet 19 1998 6 7
5. K Devriendt G Matthijs E Legius Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita Am J Hum Genet 60 1997 581 587
6. TJ Vulliamy SW Knight I Dokal PJ Mason Skewed X-inactivation in carriers of X-linked dyskeratosis congenita Blood 90 1997 2213 2216